Rudolf Widmann
- Business
AOP Orphan reports full validity of arbitral award against PharmaEssentia
Dr Rudolf Widmann, Chief Therapeutics Development Officer, Board Member, Founder, AOP Orphan Pharmaceuticals AG. (Copyright: bell&sass) Vienna, Austria: Today the…
Read More »